Prognostic Significance of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients with Diffuse Large B-Cell Lymphoma

Table 3

Multivariate analysis of clinical factors for PFS and OS according to PLR.

Characteristics	OS			PFS
	HR	95%CI	P value	HR	95%CI	P value
B symptoms	1.270	0.649-2.483	0.485	1.471	0.758-2.855	0.254
ECOG PS (⩾2)	0.753	0.234-2.423	0.635	0.711	0.222-2.277	0.566
LDH (>ULN)	1.704	0.719-4.036	0.046	1.895	0.813-4.419	0.039
Stage (III and IV)	0.823	0.350-1.934	0.655	0.801	0.339-1.895	0.614
IPI (>2)	1.252	0.707-2.217	0.041	1.168	0.659-2.070	0.044
Extranodal sites of disease (>1)	1.411	0.526-3.781	0.494	1.412	0.524-3.806	0.495
PLR⩾2.32	1.549	0.868-2.763	0.038	1.458	0.818-2.597	0.041